Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 08 Jan 2025 for Poseida Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleCharles M. Baum
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Charles M. Baum: trading record in brief
Charles M. Baum, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Mirati Therapeutics, Inc. and Poseida Therapeutics, Inc. We count 18 filings; the first trade dates from 18 June 2021 and the latest from 8 January 2025.
The open-market record consists of 2 sales worth €690k, with no purchase. The rest of the record consists of 8 share grants and 3 option exercises.
The record was last updated on 8 January 2025 with a transaction in Poseida Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Charles M. Baum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
78,600 sharesCommon StockSEC:0001415889-25-001085:0
19,650 shares0Common StockSEC:0000950170-24-074864:0
123,389 sharesCommon StockSEC:0001140361-24-003528:0
94,057 sharesCommon StockSEC:0001140361-24-003528:1
20,425 sharesCommon StockSEC:0001140361-24-003528:2
20,425 shares@ US$58.7516.5% of flowCommon StockSEC:0001628280-24-000277:0
54,054 shares@ US$37.0027.7% of flowCommon StockSEC:0001628280-23-028884:0
19,650 shares0Common StockSEC:0000950170-23-028605:0
4,444 shares0Common StockSEC:0001214659-23-001049:0
3,648 shares@ US$46.602.5% of flowCommon StockSEC:0001214659-23-000290:0
53,618 shares0Common StockSEC:0001214659-22-015200:0
69,256 shares@ US$17.4117.7% of flowCommon StockSEC:0001214659-22-014229:0
39,300 shares0Common StockSEC:0001209191-22-037669:0
25,543 shares0Common StockSEC:0001214659-22-000856:0
4,045 shares@ US$147.739.8% of flowCommon StockSEC:0001214659-22-000419:0
7,430 shares0Common StockSEC:0001214659-21-013378:0
47,204 shares@ US$8.496.6% of flowCommon StockSEC:0001214659-21-012712:0
40,000 shares@ US$8.495.3% of flowCommon StockSEC:0001214659-21-006762:0
18 of 18 declarations
